We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+135.58%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$88.6M
AUM Growth
+$16.2M
Cap. Flow
-$1.57M
Cap. Flow %
-1.77%
Top 10 Hldgs %
99.28%
Holding
21
New
3
Increased
7
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
AGRX
Agile Therapeutics
AGRX
+$1.04M
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$278K
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$170K
4
GARS
Garrison Capital Inc.
GARS
+$155K
5
CDTX
Cidara Therapeutics
CDTX
+$72.4K

Top Sells

Rank Stock Value
1
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$1.84M
2
ACAS
American Capital Ltd
ACAS
+$1.04M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$221K
4
ABUS icon
Arbutus Biopharma
ABUS
+$173K
5
ASMB icon
Assembly Biosciences
ASMB
+$111K

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.02%
2 Healthcare 20.64%
3 Financials 2.67%
4 Industrials 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPXX
1
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$67.4M 76%
2,232,272
-90,497
-4% -$1.84M
AGRX
2
DELISTED
Agile Therapeutics
AGRX
$12M 13.57%
790
+76
+11% +$1.04M
MDGL icon
3
Madrigal Pharmaceuticals
MDGL
$12.5B
$5.67M 6.39%
622,019
+1,881
+0.3% +$22.6K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.29M 1.46%
8,945
-171
-2% -$24.4K
CSW
5
CSW Industrials
CSW
$5.03B
$367K 0.41%
11,253
+347
+3% +$11.3K
SCM icon
6
Stellus Capital Investment Corp
SCM
$250M
$304K 0.34%
29,728
+6,239
+27% +$63.2K
ICMB icon
7
Investcorp Credit Management BDC
ICMB
$12.8M
$295K 0.33%
33,480
+5,062
+18% +$43.5K
PRTK
8
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$263K 0.3%
+18,909
New +$278K
DOV icon
9
Dover
DOV
$26B
$223K 0.25%
3,991
-76
-2% -$4.1K
CDTX
10
DELISTED
Cidara Therapeutics
CDTX
$194K 0.22%
940
+299
+47% +$72.4K
PFX icon
11
PhenixFIN
PFX
$88.8M
$167K 0.19%
1,246
-109
-8% -$14.4K
ACSF
12
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$157K 0.18%
15,255
-202
-1% -$2.06K
GARS
13
DELISTED
Garrison Capital Inc.
GARS
$152K 0.17%
+15,104
New +$155K
SBBP
14
DELISTED
Strongbridge Biopharma plc.
SBBP
$143K 0.16%
+35,977
New +$170K
MDGL icon
15
CALL
Madrigal Pharmaceuticals
MDGL
$12.5B
$19K 0.02%
2,057
+143
+7% +$1.72K
ABUS icon
16
Arbutus Biopharma
ABUS
$1.02B
– –
-41,903
Closed -$173K
ASMB icon
17
Assembly Biosciences
ASMB
$745M
– –
-1,849
Closed -$111K
IWM icon
18
PUT
iShares Russell 2000 ETF
IWM
$81.2B
– –
-5,338
Closed -$591K
KPTI icon
19
Karyopharm Therapeutics
KPTI
$40.6M
– –
-1,655
Closed -$221K
SPY icon
20
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-135,186
Closed -$27.8M
ACAS
21
DELISTED
American Capital Ltd
ACAS
– –
-68,537
Closed -$1.04M

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q2 2016 Portfolio in Review

As of Q2 2016, Caxton Corporation held 21 positions worth $88.6M, up 22% from $72.5M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Caxton Corporation's Q2 2016 filing shows 3 new, 7 increased, 5 reduced and 6 closed positions. Its largest new stake was Paratek Pharmaceuticals, Inc.: 18,909 shares worth $263K. The largest sale was CELATOR PHARMACEUTICALS INC. COMMON STOCK, an estimated $1.84M.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, up from 75% a quarter earlier, followed by Healthcare and Financials.

  • Caxton Corporation's largest Q2 2016 buy was Paratek Pharmaceuticals, Inc.: 18,909 shares worth $263K.
  • Caxton Corporation added most to Agile Therapeutics in Q2 2016, an estimated $1.04M increase.
  • Caxton Corporation's biggest Q2 2016 reduction was CELATOR PHARMACEUTICALS INC. COMMON STOCK, cutting an estimated $1.84M.
  • Caxton Corporation fully exited American Capital Ltd in Q2 2016, selling an estimated $1.04M.
  • Caxton Corporation's ten largest holdings make up 99% of its $88.6M portfolio in Q2 2016.
  • Caxton Corporation opened 3 new positions and closed 6 in Q2 2016.
  • Caxton Corporation's portfolio value rose 22% quarter-over-quarter to $88.6M.

Based on Caxton Corporation's 13F filing for Q2 2016, filed 15 Aug 2016.